ASX - By Stock
|
EOS |
Re:
Ann: Successful A$15 million placement and launch of SPP
|
|
Meleva69
|
61 |
27K |
5 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
61
|
27K
|
5
|
|
ASX - By Stock
|
LSF |
Re:
Performance Fee Happy Time
|
|
Meleva69
|
32 |
10K |
1 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Finalizes Ph 3 Study Designs and Startup Activities
|
|
Meleva69
|
55 |
19K |
3 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
55
|
19K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Half Year Report and Accounts
|
|
Meleva69
|
27 |
8.5K |
1 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
27
|
8.5K
|
1
|
|
ASX - By Stock
|
BCT |
Re:
Price Action
|
|
Meleva69
|
12 |
4.7K |
2 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
12
|
4.7K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Megan joins Invex
|
|
Meleva69
|
9 |
3.3K |
0 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
9
|
3.3K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
Meleva69
|
88 |
47K |
0 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
88
|
47K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
Meleva69
|
37 |
8.9K |
5 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
37
|
8.9K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
Meleva69
|
6 |
4.0K |
0 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
6
|
4.0K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
Meleva69
|
11 |
3.9K |
0 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
11
|
3.9K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
News: OPT Opthea Priced IPO In U.S. Of 8.6 Million American Depositary Shares
|
|
Meleva69
|
10 |
7.2K |
2 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
10
|
7.2K
|
2
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Change in substantial holding
|
|
Meleva69
|
37 |
11K |
0 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
37
|
11K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Plans for Potential US listing and IPO
|
|
Meleva69
|
36 |
16K |
0 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
36
|
16K
|
0
|
|
ASX - By Stock
|
PET |
Re:
Ann: Business Update
|
|
Meleva69
|
78 |
30K |
15 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
78
|
30K
|
15
|
|
ASX - By Stock
|
PET |
Re:
Ann: Response to ASX Query
|
|
Meleva69
|
59 |
22K |
26 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
59
|
22K
|
26
|
|
ASX - By Stock
|
PET |
Re:
Ann: Market Update
|
|
Meleva69
|
205 |
68K |
22 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
205
|
68K
|
22
|
|
ASX - By Stock
|
PET |
Re:
Ann: Trading Halt
|
|
Meleva69
|
79 |
30K |
4 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
79
|
30K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
Meleva69
|
124 |
51K |
2 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
124
|
51K
|
2
|
|